General Inception, a global biotech company igniter, and Enable Medicine, a leader in AI-led data analysis for biological research and drug discovery, announce an equity and strategic partnership which will amplify their joint drug discovery capabilities. As part of this partnership, General Inception is acquiring Enable for an undisclosed amount. The strategic partnership will give General Inception greater access to Enable Medicine’s biological data platform, benefiting life science and biopharmaceutical researchers, while Enable Medicine will benefit from General Inception’s drug development expertise and biotech ecosystem.
Read the full article: General Inception Acquires Enable Medicine //
Source: https://www.prnewswire.com/news-releases/general-inception-acquires-enable-medicine-and-announces-strategic-partnership-to-accelerate-drug-discovery-with-ai-led-generative-biological-search-302329523.html